Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
Reproductive Biology and Toxicology Research Laboratory, Oasis of Grace Hospital, Osogbo, Osun State, Nigeria.
Front Endocrinol (Lausanne). 2023 Jul 17;14:1180085. doi: 10.3389/fendo.2023.1180085. eCollection 2023.
Although, codeine has been demonstrated to lower sperm quality; the effects of maternal and prepubertal codeine exposure on male offspring is yet to be reported. In addition, the effect of arginine on codeine-induced decline in sperm quality has not been explored. This study investigated the impact of maternal and prepubertal codeine exposure on spermatogenesis and sperm quality in F1 male Wistar rats to study the effect that codeine may have during recreational use in humans. Also, the effect of arginine supplementation on codeine-induced alteration in spermatogenesis and sperm quality was evaluated.
Female rats were treated with either 0.5 ml distilled water or codeine orally for eight weeks, and then mated with male rats (female:male, 2:1). The F1 male offsprings of both cohorts were weaned at 3 weeks old and administered distilled water, codeine, arginine, or codeine with arginine orally for eight weeks.
Prepubertal codeine exposure in rats whose dams (female parents) were exposed to codeine delayed puberty and reduced the weight at puberty. Prepubertal codeine exposure exacerbated maternal codeine exposure-induced reduced total and daily spermatid production, sperm count, sperm motility, and normal sperm form, as well as impaired sperm plasma membrane integrity and increased not intact acrosome and damaged sperm DNA integrity. These perturbations were accompanied by a decrease in mRNA levels encoding spermatogenic genes, testicular testosterone and androgen receptor (AR) concentrations, and upregulation of sperm 8-hydroxydeoxyguanosine (8OHdG). Prepubertal arginine supplementation mitigated codeine-induced alterations.
This study provides novel experimental evidence that maternal and prepubertal codeine exposure reprogramed spermatogenesis and sperm quality of male FI generation by decreasing mRNA levels encoding spermatogenic genes and AR via oxidative stress-mediated signaling, which was abrogated by prepubertal arginine supplementation.
尽管已证实可待因可降低精子质量,但母体和青春期前可待因暴露对雄性后代的影响尚未见报道。此外,精氨酸对可待因引起的精子质量下降的影响尚未被探索。本研究调查了母体和青春期前可待因暴露对 F1 雄性 Wistar 大鼠生殖的影响,以研究人类在娱乐性使用时可待因可能产生的影响。此外,还评估了精氨酸补充对可待因诱导的生殖改变和精子质量的影响。
雌性大鼠分别用 0.5ml 蒸馏水或可待因口服处理 8 周,然后与雄性大鼠交配(雌性:雄性,2:1)。两个队列的 F1 雄性后代在 3 周龄时断奶,并分别给予蒸馏水、可待因、精氨酸或可待因和精氨酸口服 8 周。
母体暴露于可待因的大鼠(母代)的青春期前可待因暴露延迟了青春期并降低了青春期时的体重。青春期前可待因暴露加重了母体可待因暴露引起的总精子和日精子生成减少、精子计数减少、精子活力下降和正常精子形态受损,以及精子质膜完整性受损、顶体不全增加和精子 DNA 完整性受损。这些改变伴随着编码精子发生基因、睾丸睾酮和雄激素受体(AR)浓度的 mRNA 水平降低,以及精子 8-羟基脱氧鸟苷(8OHdG)水平升高。青春期前精氨酸补充减轻了可待因诱导的改变。
本研究提供了新的实验证据,表明母体和青春期前可待因暴露通过氧化应激介导的信号通路降低编码精子发生基因和 AR 的 mRNA 水平,从而重塑了雄性 F1 代的精子发生和精子质量,这种重塑被青春期前的精氨酸补充所阻断。